Overall Status

Active, not recruiting (2)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Collaborator

NRG Oncology (1)

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (1)

multi-epitope folate receptor alpha-loaded dendritic cell vaccine (1)

olaparib (1)

tremelimumab (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

fallopian tube endometrioid tumor

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor Trial

Active, not recruiting

Fallopian Tube Endometrioid Tumor
+13 more

Olaparib
Tremelimumab

Orange, California
+19 more

Jan 10, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting

Fallopian Tube Clear Cell Adenocarcinoma
+22 more

Laboratory Biomarker Analysis
Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine

Rochester, Minnesota

Mayo Clinic

Oct 7, 2022